Streetbeat News

BBRRF

Blueberries Medical Corp

http://www.blueberriesmed.com/

Industry

Medicinal and Botanical Manufacturing

Open

0.01

Mkt cap

3.8M

Volume

10K

High

0.01

P/E Ratio

-0.95

52-wk high

0.03

Low

0.01

Div yield

N/A

52-wk low

0.01

Marijuana stocks experienced significant movement on a recent Friday, with Choom Holdings leading the gainers with a 9900.00% increase, while EVIO was the top loser, dropping 98.00%. Other notable gainers include Affinor Growers, Blueberries Medical, and Indiva. On the losing side, Global Hemp Group and Pharmadrug also saw notable declines. The volatility in these stocks reflects the dynamic nature of the cannabis industry.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 9:30 pm

The article lists the cannabis stocks that experienced significant gains and losses on January 2, 2024. Notable gainers include Global Hemp Group, Khiron Life Sciences, and 1933 Industries, with increases of 238.24%, 50.00%, and 31.82% respectively. On the losing side, Item 9 Labs, AusCann Group Holdings, and Blueberries Medical saw declines of 18.42%, 14.67%, and 10.29%. The article also mentions several other cannabis-related companies with smaller gains and losses.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 9:30 pm

Blueberries Medical Corp. (OTC:BBRRF) announced a non-brokered private placement of 180,716,00 common shares at $0.0083 per share, raising approximately $1.99 million. The proceeds will repay debt and support general corporate purposes. The offering was led by Terraflos Inc., with plans to expand into Argentina, Mexico, and Brazil. Blueberries also has a joint venture with Allied Corp. (OTCQB:ALID) for the production of cannabis derivatives. Post-announcement, BBRRF shares rose 12.7451% to $0.0138.

Portfolio Pulse from Jelena Martinovic

January 02, 2024 | 4:10 pm

The article reports on significant price movements in marijuana stocks on January 1, 2024. Notable gainers include Cann Gr, Item 9 Labs, cbdMD, and others with increases ranging from 4.62% to 68.33%. Conversely, several companies experienced declines, with GrowLife leading the losers, dropping 66.67%. Other notable losers include Khiron Life Sciences, MJ Holdings, and OrganiGram Holdings, with decreases ranging from 3.10% to 25.00%. The article was produced by Benzinga's automated content engine.

Portfolio Pulse from Benzinga Insights

January 01, 2024 | 9:30 pm

On December 29, 2023, several cannabis stocks experienced significant movements. Notable gainers included Cann Gr, Item 9 Labs, and Maple Leaf Green World, with increases of 68.33%, 35.71%, and 24.21% respectively. Conversely, GrowLife, Khiron Life Sciences, and MJ Holdings were among the biggest losers, with declines of 66.67%, 25.00%, and 19.37%. OrganiGram Holdings, Village Farms Intl, and Tilray Brands, all NASDAQ-listed, also saw their shares drop by 7.80%, 4.76%, and 3.73%.

Portfolio Pulse from Benzinga Insights

December 29, 2023 | 9:30 pm

On December 28, 2023, several cannabis stocks experienced significant price movements. Notable gainers included GrowLife, Rhinomed, AusCann Group Holdings, Khiron Life Sciences, and Cara Therapeutics, with GrowLife leading the surge with a 200% increase. On the losing end, The Flowr Corporation saw a dramatic 99.99% decline. Other decliners included CordovaCann, Rocky Mountain High, and Item 9 Labs. The cannabis sector showed high volatility with these sharp price changes.

Portfolio Pulse from Benzinga Insights

December 28, 2023 | 9:30 pm

On December 27, 2023, several marijuana stocks experienced significant price movements. Notable gainers included Affinor Growers, GrowLife, and Rocky Mountain High, with Affinor Growers leading the surge with a 668% increase. On the losing side, AusCann Group Holdings saw the largest decline, dropping 44%. Other notable losers included Global Hemp Group and C21 Investments. The movements reflect the volatility and investor sentiment in the cannabis industry.

Portfolio Pulse from Benzinga Insights

December 27, 2023 | 9:30 pm

Cannabis stocks experienced significant movements on December 26, 2023. Notable gainers included GrowLife, 4Front Ventures, and C21 Investments, with increases of 40%, 22.53%, and 22.16% respectively. Canopy Growth, Eastside Distilling, Cresco Labs, and Tilray Brands also saw gains on NASDAQ. Conversely, Affinor Growers and Cann Gr were among the biggest losers, with shares dropping 58.79% and 57.02%. Urban-gro, Psychemedics, and Neptune Wellness Solutions were among NASDAQ-listed companies that saw their stock prices decline.

Portfolio Pulse from Benzinga Insights

December 26, 2023 | 9:30 pm

On December 21, 2023, several marijuana stocks experienced significant price movements. Notable gainers included Blueberries Medical, iAnthus Capital Holdings, and Heritage Cannabis Holding, with increases of 15.05%, 14.44%, and 12.73% respectively. Emeren Group, Corbus Pharmaceuticals, and Scotts Miracle Gro also saw their shares rise. Conversely, MJ Holdings, Khiron Life Sciences, and Item 9 Labs were among the biggest losers, with MJ Holdings dropping 30.41%. Other notable declines were observed in Eastside Distilling, Genetic Technologies, Canopy Growth, and Cresco Labs.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 9:30 pm

Marijuana stocks experienced significant movements on December 20, 2023. Canopy Growth (CGC) saw an extraordinary rise of 827.46%, while EVIO plummeted by 99%. Other notable gainers include MJ Holdings (MJNE) and Greenlane Holdings (GNLN), with increases of 46.97% and 11.65% respectively. Conversely, MPX International (MPXOF) and Cann Gr (CNGGF) faced sharp declines. The volatility in the sector is evident, with several companies experiencing double-digit percentage changes in their stock prices.

Portfolio Pulse from Benzinga Insights

December 20, 2023 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.